A Multicenter, Randomized, Open-label, Phase 2 Study of Carfilzomib With or Without ARRY-520 in Patients With Advanced Multiple Myeloma
Phase of Trial: Phase II
Latest Information Update: 31 Jul 2016
Price : $35 *
At a glance
- Drugs Filanesib (Primary) ; Carfilzomib; Dexamethasone; Filgrastim
- Indications Multiple myeloma
- Focus Registrational; Therapeutic Use
- Sponsors Array BioPharma
- 01 Jun 2016 Status changed from active, no longer recruiting to completed.
- 11 Feb 2016 Planned primary completion date changed from 1 Dec 2016 to 1 Feb 2016 as reported by ClinicalTrials.gov.
- 11 Feb 2016 Planned primary completion date changed from 1 Dec 2015 to 1 Dec 2016 as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History